BLSM
BlossomHill Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$15.21
−7.59%Next report
Analyst consensus
- Next report date
- Dec 18, 2026
- EPS estimate
- -$0.93
- Revenue estimate
- —
Latest reported
- Last report date
- Sep 18, 2026
- EPS actual
- -$8.75
- EPS estimate
- -$0.93
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -844.9%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 18, 2026 | -$0.93 | -$8.75 | Miss -844.92% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 18, 2026